Refine by
Central Vision Suppliers & Manufacturers
6 companies found
based inParis, FRANCE
Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling ...
The Prima System is intended to partially replace the normal physiological function of the eye’s photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via ...
based inBlue Springs, MONTANA (USA)
When Durvet opened for business in 1970, its doors were literally attached to a van carrying its animal health care products warehoused in a tiny 500 square foot rented facility. Durvet was the first entity in the OTC animal health market to bring ...
based inGandhinagar, INDIA
Alentris Research Pvt Ltd was founded by the two scientists in Year 2017. Alentris Research are having more than 100 years of experience in synthetic organic and Medicinal chemistry. We are having 4500 square foot area for research and development ...
based inLeeds, UNITED KINGDOM
Brandon Medical is a multi-award winning UK designer and manufacturer of world-leading technology solutions for operating theatres, critical care areas and primary care institutions. For over 70 years, Brandon Medical has provided healthcare ...
Designed and manufactured in the United Kingdom, the Quasar eLite range of operating theatre lamps impresses clinical staff every time and it has with the best cost-quality ratio worldwide. Quasar® eLite has been designed by Brandon Medical in ...
based inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
OCU410 (AAV-RORA) is a modifier gene therapy product candidate being developed for the treatment of dry age-related macular degeneration (Dry AMD). OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA (RAR Related Orphan ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...